Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
VolitionRx Limited
organization5 mentionslast seen Nov 9, 2026
A multi-national epigenetics company developing and commercializing blood tests to detect and monitor diseases including cancers and sepsis.
Relationships 21
- VolitionRx LimitedemploysCameron Reynolds99% confidence4 sources
- VolitionRx Limitedpartners withIDS France99% confidence2 sources
- VolitionRx LimiteddevelopsNu.Q® NETs99% confidence2 sources
- VolitionRx Limiteddevelopsblood test99% confidence2 sources
- VolitionRx LimitedemploysTerig Hughes97% confidence1 source
- VolitionRx LimitedemploysRodney Rootsaert97% confidence1 source
- VolitionRx LimitedemploysRemi Rabeuf96% confidence1 source
- VolitionRx LimitedemploysAndrew Retter95% confidence1 source
- VolitionRx Limitedfunded bySenior secured convertible promissory note dated January 15, 202695% confidence1 source
- VolitionRx Limiteddevelopsblood test93% confidence1 source
- VolitionRx Limitedcommercializesblood test93% confidence1 source
- Assistance Publique - Hôpitaux de Parispartners withVolitionRx Limited93% confidence1 source
- Hospices Civils de Lyonpartners withVolitionRx Limited92% confidence1 source
- VolitionRx Limitedcommercializesblood test90% confidence1 source
- Lind Global Asset Management XII LLCinvests inVolitionRx Limited90% confidence1 source
- VolitionRx Limitedpartners withAssistance Publique - Hôpitaux de Paris88% confidence1 source
- VolitionRx Limitedpartners withIHU SEPSIS88% confidence1 source
- VolitionRx Limitedfunded byChallenge Prevention88% confidence1 source
- VolitionRx Limitedpartners withHospices Civils de Lyon88% confidence1 source
- Lind Global Asset Management XII LLCinvests inVolitionRx Limited85% confidence1 source
- VolitionRx Limiteddevelopsepigenetics75% confidence1 source
Relationship
VolitionRx LimitedemploysCameron Reynolds
99% confidence4 supporting mentions
Either name opens that entity’s relationships.
Sources 4
- newsPR NewswireNov 9, 2026VolitionRx Limited Schedules Third Quarter 2026 Earnings Conference Call and Business Update
Cameron Reynolds, President and Chief Executive Officer
- filingSEC EDGAROct 27, 2026VOLITIONRX LTD 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Cameron Reynolds, Chief Executive Officer, Volition
- newsPR NewswireSep 17, 2026VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France
Cameron Reynolds, Chief Executive Officer, Volition
- filingSEC EDGARSep 14, 2026VOLITIONRX LTD 8-K: Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Cameron Reynolds, Chief Executive Officer & President